The growth of Viagra and its effect on the medicinal landscape presents a complex question for shareholders. While the initial sales figures were impressive, the exclusivity has lapsed, leading to a wave of off-brand https://elijahyhkv816156.blogolenta.com/38432160/viagra-and-pharma-a-risky-investment